NCT03847428 2026-03-06
EMERALD-2
AstraZeneca
Phase 3 Active not recruiting
Clinical Trials
62 trialsNCT03778957 2026-01-16
EMERALD-1
AstraZeneca
Phase 3 Active not recruiting
NCT03383458 2025-11-21
CheckMate 9DX
Bristol-Myers Squibb
Phase 3 Active not recruiting
NCT06680258 2025-09-03
A Study of TPST-1120 With Atezolizumab Plus Bevacizumab in Patients With Unresectable or Metastatic HCC Not Previously Treated With Systemic Therapy
Tempest Therapeutics
Phase 3 Not yet recruiting
NCT02523443 2025-07-22
Patient Controlled Epidural Analgesia Versus Intravenous Patient Controlled Analgesia for Post-Operative Pain Control in Patients Undergoing Elective Liver Resection
Memorial Sloan Kettering Cancer Center
Phase 3 Active not recruiting
NCT05201404 2025-04-29
LIVERATION
Can-Fite BioPharma
Phase 3 Recruiting
NCT00051545 2025-02-25
Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma
LEO Pharma
Phase 3 Terminated
NCT02349412 2025-02-07
Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT05301842 2025-01-15
EMERALD-3
AstraZeneca
Phase 3 Active not recruiting
NCT04340193 2024-11-26
CheckMate 74W
Bristol-Myers Squibb
Phase 3 Completed
NCT05744219 2024-10-21
IRIS
Uppsala University Hospital
Phase 3 Recruiting
NCT02112656 2024-08-20
OPTIMA
Imunon
Phase 3 Completed
NCT04868149 2024-08-15
Clinical Outcome and Future Liver Remnant Regenerative Response in Laparoscopic Versus Open ALPPS
The University of Hong Kong
Phase 3 Recruiting
NCT03949231 2024-06-26
Infusion of PD1/PDL1/CTLA4 Inhibitors Via Hepatic Arterial for Immunotherapy of Hepatocellular Carcinoma
Second Affiliated Hospital of Guangzhou Medical University
Phase 3 Recruiting
NCT00617981 2024-05-03
Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)
Imunon
Phase 3 Completed
NCT02649153 2024-01-23
SP/GC-HCC
Guangxi Medical University
Phase 3 Completed
NCT00658593 2023-08-04
Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary Cancer
Canadian Cancer Trials Group
Phase 3 Terminated
NCT02125396 2023-01-27
ARTC-HCC
Guangxi Medical University
Phase 3 Unknown
NCT02435433 2023-01-20
REACH-2
Eli Lilly and Company
Phase 3 Completed
NCT01402908 2022-06-23
PATRON
Cellxpert Biotechnology Corp.
Phase 3 Terminated
NCT01307878 2022-06-14
New Adjuvant Chemotherapy of Asymptomatic Resectable Primary Lesion With Unresectable Liver-limited Metastases
Fudan University
Phase 3 Completed
NCT02192671 2022-01-18
HR-HCC/PHT
Guangxi Medical University
Phase 3 Unknown
NCT01908426 2021-05-06
CELESTIAL
Exelixis
Phase 3 Completed
NCT03164382 2020-12-16
Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil/Leucovorin Versus Sorafenib in Advanced Hepatocellular Carcinoma
Sun Yat-sen University
Phase 3 Completed
NCT02169765 2020-07-22
ARTC-HCC
Guangxi Medical University
Phase 3 Unknown
NCT01438476 2020-02-12
Postoperative Thoracic Epidural Analgesia Versus Intravenous Patient-Controlled Analgesia For Liver and/or Pancreas
M.D. Anderson Cancer Center
Phase 3 Completed
NCT03059238 2019-08-13
Parecoxib Versus Celecoxib Versus Oxycodone in Pain Control for Transcatheter Chemoembolization Procedure
Sun Yat-sen University
Phase 3 Completed
NCT01229839 2019-03-06
Chemoembolization With or Without Mixing the Chemotherapy With Lipiodol for Unresectable HCC
Sun Yat-sen University
Phase 3 Completed
NCT01259414 2019-03-06
Comparison of Two Solvents Used With Chemotherapy Agent for Transarterial Chemoembolization of Hepatocellular Carcinoma
Sun Yat-sen University
Phase 3 Completed
NCT02232490 2019-02-26
Hepko-V5
Immunitor LLC
Phase 3 Unknown
NCT00692770 2018-08-08
STORM
Bayer
Phase 3 Completed
NCT00829413 2018-08-03
SonoVue®-Enhanced Ultrasound (US) Versus Unenhanced US for Focal Liver Lesion Characterization
Bracco Diagnostics, Inc
Phase 3 Completed
NCT00652132 2018-05-29
SIOPEL6
University of Birmingham
Phase 3 Completed
NCT02646137 2018-01-09
Single Session Combined Locoregional Therapies for Hepatocellular Carcinoma
Tanta University
Phase 3 Unknown
NCT00788697 2017-12-12
SonoVue®-Enhanced Ultrasound Versus Unenhanced US for Focal Liver Lesion Characterization
Bracco Diagnostics, Inc
Phase 3 Completed
NCT01596283 2017-10-18
Clinical Trial of Standard Versus Goal-Directed Perioperative Fluid Management (GDT) for Patients Undergoing Liver Resection
Memorial Sloan Kettering Cancer Center
Phase 3 Completed
NCT02029157 2017-10-09
JET-HCC
Kyowa Kirin Co., Ltd.
Phase 3 Completed
NCT02568748 2017-04-27
Evaluation of Cytokine-induced Killer (CIK) Cells as Therapy or Adjuvant Treatment for Advanced HCC
Tanta University
Phase 3 Unknown
NCT01869088 2017-03-16
TACE Plus Recombinant Human Adenovirus for Hepatocellular Carcinoma
Sun Yat-sen University
Phase 3 Unknown
NCT01313377 2017-01-25
Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgery
UNICANCER
Phase 3 Completed
NCT03010085 2017-01-04
OLLEH
Ewha Womans University Mokdong Hospital
Phase 3 Unknown
NCT00109954 2016-01-18
Hepatic Arterial Chemoembolization With Cisplatin or Internal Radiation Therapy in Treating Patients With Advanced Liver Cancer That Cannot Be Removed By Surgery
University of Pittsburgh
Phase 3 Completed
NCT00440310 2015-08-25
Phase 3 Trial of Litxâ„¢ Plus Chemotherapy vs. Chemotherapy Only Treating Colorectal Cancer Patients With Recurrent Liver Metastases
Light Sciences Oncology
Phase 3 Completed
NCT00902343 2015-08-13
Controlled Trial Comparing Nomogram-based Versus Standard Allocation of Acute Normovolemic Hemodilution (ANH) During Hepatic Resection
Memorial Sloan Kettering Cancer Center
Phase 3 Completed
NCT00355355 2015-01-30
A Phase 3 Study of Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC)
Light Sciences Oncology
Phase 3 Completed
NCT00105443 2014-10-31
SHARP
Bayer
Phase 3 Completed
NCT02038296 2014-01-17
Different Protocols for Repeated Transarterial Chemoembolization in the Treatment of Patients With Hepatocellular Carcinoma
Guangdong Provincial People's Hospital
Phase 3 Completed
NCT00494299 2013-12-20
Phase III Study of BAY43-9006 in Patients With Advanced Hepatocellular Carcinoma (HCC) Treated After Transcatheter Arterial Chemoembolization (TACE)
Bayer
Phase 3 Completed
NCT00079027 2013-12-18
Doxorubicin By Infusion or Chemoembolization in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer)
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00003912 2013-12-04
Chemotherapy in Treating Children With Liver Cancer
National Cancer Institute (NCI)
Phase 3 Completed